[1]
“A robust stability indicating HPLC technique for evalution of Pibrentasvir and Glecaprevir in tablet dosage form”, Int. Jrnl.. Res. Pharm. Chem. & Analy, vol. 1, no. 4, pp. 88–94, Mar. 2024, Accessed: Oct. 24, 2025. [Online]. Available: https://rubatosis.org/journals/index.php/ijrpca/article/view/109